← Open Payments lookup

BOGUSLAW GLUSZAK: Open Payments

NPI 1689632994 · BOLIVAR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,588 in 97 payments from 11 companies in 2025. Trend: 2023 $195 · 2024 $2,577 · 2025 $1,588

Food & beverage: $1,588
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.20$381
Teva Pharmaceuticals USA, Inc.36$255
ABBVIE INC.10$213
Vanda Pharmaceuticals Inc.5$171
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$152
Janssen Pharmaceuticals, Inc4$115
E.R. Squibb & Sons, L.L.C.5$114
Alkermes, Inc.4$70
Supernus Pharmaceuticals, Inc.3$54
Otsuka America Pharmaceutical, Inc.2$33

Products named: INGREZZA, VRAYLAR, AUSTEDO XR, CAPLYTA, HETLIOZ, COBENFY, INVEGA, ARISTADA.

Industry payments across MO — which companies pay providers there.